These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31437241)

  • 1. Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice.
    Cesaro A; Defrêne J; Lachhab A; Pagé N; Tardif MR; Al-Shami A; Oravecz T; Fortin PR; Daudelin JF; Labrecque N; Aoudjit F; Pelletier M; Tessier PA
    PLoS One; 2019; 14(8):e0221528. PubMed ID: 31437241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fcγ receptor-mediated influx of S100A8/A9-producing neutrophils as inducer of bone erosion during antigen-induced arthritis.
    Di Ceglie I; Ascone G; Cremers NAJ; Sloetjes AW; Walgreen B; Vogl T; Roth J; Verbeek JS; van de Loo FAJ; Koenders MI; van der Kraan PM; Blom AB; van den Bosch MHJ; van Lent PLEM
    Arthritis Res Ther; 2018 May; 20(1):80. PubMed ID: 29720243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
    Geven EJ; van den Bosch MH; Di Ceglie I; Ascone G; Abdollahi-Roodsaz S; Sloetjes AW; Hermann S; Schäfers M; van de Loo FA; van der Kraan PM; Koenders MI; Foell D; Roth J; Vogl T; van Lent PL
    Arthritis Res Ther; 2016 Oct; 18(1):247. PubMed ID: 27776554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout mice.
    Di Ceglie I; van Lent PLEM; Geven EJW; Koenders MI; Blom AB; Vogl T; Roth J; van den Bosch MHJ
    Arthritis Res Ther; 2021 Aug; 23(1):216. PubMed ID: 34412663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A8/A9 increases the mobilization of pro-inflammatory Ly6C
    Cremers NAJ; van den Bosch MHJ; van Dalen S; Di Ceglie I; Ascone G; van de Loo F; Koenders M; van der Kraan P; Sloetjes A; Vogl T; Roth J; Geven EJW; Blom AB; van Lent PLEM
    Arthritis Res Ther; 2017 Sep; 19(1):217. PubMed ID: 28969686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
    van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
    van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
    Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
    Flynn MC; Kraakman MJ; Tikellis C; Lee MKS; Hanssen NMJ; Kammoun HL; Pickering RJ; Dragoljevic D; Al-Sharea A; Barrett TJ; Hortle F; Byrne FL; Olzomer E; McCarthy DA; Schalkwijk CG; Forbes JM; Hoehn K; Makowski L; Lancaster GI; El-Osta A; Fisher EA; Goldberg IJ; Cooper ME; Nagareddy PR; Thomas MC; Murphy AJ
    Circ Res; 2020 Sep; 127(7):877-892. PubMed ID: 32564710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8/A9.
    Mantelmacher FD; Zvibel I; Cohen K; Epshtein A; Pasmanik-Chor M; Vogl T; Kuperman Y; Weiss S; Drucker DJ; Varol C; Fishman S
    Nat Metab; 2019 Jan; 1(1):58-69. PubMed ID: 32694806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis.
    Schelbergen RF; de Munter W; van den Bosch MH; Lafeber FP; Sloetjes A; Vogl T; Roth J; van den Berg WB; van der Kraan PM; Blom AB; van Lent PL
    Ann Rheum Dis; 2016 Jan; 75(1):218-25. PubMed ID: 25180294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
    van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
    McNeill E; Hogg N
    Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis.
    Grevers LC; de Vries TJ; Vogl T; Abdollahi-Roodsaz S; Sloetjes AW; Leenen PJ; Roth J; Everts V; van den Berg WB; van Lent PL
    Arthritis Rheum; 2011 May; 63(5):1365-75. PubMed ID: 21337316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis.
    Jin S; Park CO; Shin JU; Noh JY; Lee YS; Lee NR; Kim HR; Noh S; Lee Y; Lee JH; Lee KH
    Exp Dermatol; 2014 Dec; 23(12):938-41. PubMed ID: 25308296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the KSRP gene modifies collagen antibody induced arthritis.
    Käfer R; Schrick K; Schmidtke L; Montermann E; Hobernik D; Bros M; Chen CY; Kleinert H; Pautz A
    Mol Immunol; 2017 Jul; 87():207-216. PubMed ID: 28511090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
    Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock.
    Heinemann AS; Pirr S; Fehlhaber B; Mellinger L; Burgmann J; Busse M; Ginzel M; Friesenhagen J; von Köckritz-Blickwede M; Ulas T; von Kaisenberg CS; Roth J; Vogl T; Viemann D
    FASEB J; 2017 Mar; 31(3):1153-1164. PubMed ID: 27993995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.